[Federal Register Volume 83, Number 10 (Tuesday, January 16, 2018)]
[Notices]
[Pages 2283-2289]
[FR Doc No: 2018-00561]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2017-0286]

Qualification of Drivers; Exemption Applications; Diabetes
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of applications for exemption; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 40 individuals
for an exemption from the prohibition in the Federal Motor Carrier
Safety Regulations (FMCSRs) against persons with insulin-treated
diabetes mellitus (ITDM) operating a commercial motor vehicle (CMV) in
interstate commerce. If granted, the exemptions would enable these
individuals with ITDM to operate CMVs in interstate commerce.

DATES: Comments must be received on or before February 15, 2018.

ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket No. FMCSA-2017-0286 using any of the
following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the online instructions for submitting
comments.
     Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m.,
e.t., Monday through Friday, except Federal Holidays.
     Fax: 1-202-493-2251.
    Instructions: Each submission must include the Agency name and the
docket number(s) for this notice. Note that all comments received will
be posted without change to http://www.regulations.gov, including any
personal information provided. Please see the Privacy Act heading below
for further information.

    Docket: For access to the docket to read background documents or
comments, go to http://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE,
Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday,
except Federal holidays. The FDMS is available 24 hours each day e.t.,
365 days each year. If you want acknowledgment that we received your
comments, please include a self-addressed, stamped envelope or postcard
or print the acknowledgement page that appears after submitting
comments online.
    Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to http://www.regulations.gov, as described in
the system of records notice (DOT/ALL-14 FDMS), which can be reviewed
at http://www.dot.gov/privacy.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division,<PHONE_NUMBER>, [email protected], FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224,
Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t.,
Monday through Friday, except Federal holidays. If you have questions
regarding viewing or submitting material to the docket, contact Docket
Services, telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the FMCSRs for a five-year period if it finds ``such exemption
would likely achieve a level of safety that is equivalent to or greater
than the level that would be achieved absent such exemption.'' The
statute also allows the Agency to renew exemptions at the end of the
five-year period. FMCSA grants exemptions from the FMCSRs for a two-
year period to align with the maximum duration of a driver's medical
certification.
    The 40 individuals listed in this notice have requested an
exemption from the diabetes prohibition in 49 CFR 391.41(b)(3).
Accordingly, the Agency will evaluate the qualifications of each
applicant to determine whether granting the exemption will achieve the
required level of safety mandated by statute.
    The physical qualification standard for drivers regarding diabetes
found in 49 CFR 391.41(b)(3) states that a person is physically
qualified to drive a CMV if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control. The Agency established the current requirement for
diabetes in 1970 because several risk studies indicated that drivers
with diabetes had a higher rate of crash involvement than the general
population.
    FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal
Register notice in conjunction with the November 8, 2005 (70 FR 67777),
Federal Register notice provides the current protocol for allowing such
drivers to operate CMVs in interstate commerce.
    FMCSA notes that section 4129 of the Safe, Accountable, Flexible
and Efficient Transportation Equity Act: A Legacy for Users requires
the Secretary to revise its diabetes exemption program established on
September 3, 2003 (68 FR 52441). The revision must provide for
individual assessment of drivers with diabetes mellitus, and be
consistent with the criteria described in section 4018 of the
Transportation Equity Act for the 21st Century (49 U.S.C. 31305).
Section 4129 requires: (1) Elimination of the requirement for three
years of experience operating CMVs while being treated with insulin;
and (2) establishment of a specified minimum period of insulin use to
demonstrate stable control of diabetes before being allowed to operate
a CMV.
    In response to section 4129, FMCSA made immediate revisions to the
diabetes exemption program established by the September 3, 2003 notice.
FMCSA discontinued use of the three-year driving experience and
fulfilled the requirements of section 4129 while continuing to ensure
that operation of CMVs by drivers with ITDM will achieve the requisite
level of safety required of all exemptions granted under 49 U.S.C.
31136 (e). Section 4129(d) also directed FMCSA to ensure that drivers
of CMVs with ITDM are not held to a higher standard than other drivers,
with the exception of limited operating, monitoring and medical
requirements that are deemed medically necessary. The FMCSA concluded
that all of the operating, monitoring and medical requirements set out
in the September 3, 2003, notice, except as modified, were in
compliance with section 4129(d). Therefore, all of the requirements set
out in the September 3, 2003, notice, except as modified by the notice
in the Federal Register on November 8, 2005 (70 FR 67777), remain in
effect.

II. Qualifications of Applicants

Kyle A. Bernard

    Mr. Bernard, 29, has had ITDM since 1994. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Bernard understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Bernard meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he has stable
nonproliferative diabetic retinopathy. He holds an operator's license
from Pennsylvania.

Zachary R. Brigham

    Mr. Brigham, 30, has had ITDM since 1997. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Brigham understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Brigham meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds an operator's license from South
Carolina.

Kenneth D. Chitwood

    Mr. Chitwood, 53, has had ITDM since 2010. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of

consciousness, requiring the assistance of another person, or resulting
in impaired cognitive function that occurred without warning in the
past 12 months and no recurrent (two or more) severe hypoglycemic
episodes in the last five years. His endocrinologist certifies that Mr.
Chitwood understands diabetes management and monitoring, has stable
control of his diabetes using insulin, and is able to drive a CMV
safely. Mr. Chitwood meets the requirements of the vision standard at
49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and
certified that he does not have diabetic retinopathy. He holds a Class
B CDL from Pennsylvania.

Tony M. Damesworth

    Mr. Damesworth, 75, has had ITDM since 2005. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Damesworth understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Damesworth meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from
Tennessee.

Walter Dudiak

    Mr. Dudiak, 74, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Dudiak understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Dudiak meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he does not
have diabetic retinopathy. He holds a Class C CDL from Pennsylvania.

Mark T. Feldmann

    Mr. Feldmann, 26, has had ITDM since 2016. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Feldmann understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Feldmann meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Kentucky.

John H. Fritz

    Mr. Fritz, 72, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Fritz understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Fritz meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Indiana.

Scott T. Fry

    Mr. Fry, 46, has had ITDM since 2016. His endocrinologist examined
him in 2017 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (two or
more) severe hypoglycemic episodes in the last five years. His
endocrinologist certifies that Mr. Fry understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Fry meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined
him in 2017 and certified that he does not have diabetic retinopathy.
He holds an operator's license from Colorado.

Richard E. Henderson

    Mr. Henderson, 63, has had ITDM since 2016. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Henderson understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Henderson meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Arizona.

Leah M. Hennes

    Ms. Hennes, 23, has had ITDM since 2007. Her endocrinologist
examined her in 2017 and certified that she has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. Her endocrinologist certifies that Ms. Hennes understands
diabetes management and monitoring has stable control of her diabetes
using insulin, and is able to drive a CMV safely. Ms. Hennes meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). Her
optometrist examined her in 2017 and certified that she does not have
diabetic retinopathy. She holds an operator's license from Minnesota.

Gerard M. Hubert

    Mr. Hubert, 54, has had ITDM since 2012. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Hubert understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV

safely. Mr. Hubert meets the requirements of the vision standard at 49
CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and
certified that he does not have diabetic retinopathy. He holds a Class
B CDL from Massachusetts.

Gregory L. Humphrey

    Mr. Humphrey, 50, has had ITDM since 2016. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Humphrey understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Humphrey meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Illinois.

Parkinson B. James

    Mr. James, 57, has had ITDM since 2009. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. James understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. James meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he has stable
proliferative diabetic retinopathy. He holds a Class B CDL from New
York.

John M. Jessup

    Mr. Jessup, 59, has had ITDM since 2016. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Jessup understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Jessup meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class C CDL from Michigan.

Kevin A. Kirker

    Mr. Kirker, 54, has had ITDM since 2011. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Kirker understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Kirker meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Wisconsin.

Ryan A. Knutson

    Mr. Knutson, 38, has had ITDM since 2008. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Knutson understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Knutson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from South Dakota.

Benjamin T. Lamoreaux

    Mr. Lamoreaux, 42, has had ITDM since 2016. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Lamoreaux understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Lamoreaux meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Florida.

Joseph W. Latawiec

    Mr. Latawiec, 63, has had ITDM since 2004. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Latawiec understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Latawiec meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from
Minnesota.

Tommy Leyva

    Mr. Leyva, 61, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Leyva understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Leyva meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class B CDL from
California.

Melvin Lumpkins, III

    Mr. Lumpkins, 50, has had ITDM since 2012. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic

reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (two or
more) severe hypoglycemic episodes in the last five years. His
endocrinologist certifies that Mr. Lumpkins understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Lumpkins meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from
Louisiana.

Craig E. Lynn

    Mr. Lynn, 58, has had ITDM since 2017. His endocrinologist examined
him in 2017 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (two or
more) severe hypoglycemic episodes in the last five years. His
endocrinologist certifies that Mr. Lynn understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Lynn meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2017 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from Georgia.

Charles E. Madenford, III

    Mr. Madenford, 51, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Madenford understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Madenford meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Pennsylvania.

David R. Meddows

    Mr. Meddows, 55, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Meddows understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Meddows meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Illinois.

Kevin L. Miller

    Mr. Miller, 54, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Miller understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Miller meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Pennsylvania.

Charles A. Moerer

    Mr. Moerer, 50, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Moerer understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Moerer meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Indiana.

Cirilo M. Nunez

    Mr. Nunez, 64, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Nunez understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Nunez meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from New Jersey.

LaVonda B. Pearson

    Ms. Pearson, 52, has had ITDM since 2009. Her endocrinologist
examined her in 2017 and certified that she has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. Her endocrinologist certifies that Ms. Pearson understands
diabetes management and monitoring has stable control of her diabetes
using insulin, and is able to drive a CMV safely. Ms. Pearson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). Her
optometrist examined her in 2017 and certified that she does not have
diabetic retinopathy. She holds an operator's license from North
Carolina.

Andrea N. Pressley

    Ms. Pressley, 48, has had ITDM since 2012. Her endocrinologist
examined her in 2017 and certified that she has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. Her endocrinologist certifies that Ms. Pressley understands
diabetes management and monitoring has stable control of her diabetes
using insulin, and is able to drive a CMV safely. Ms. Pressley meets
the requirements of the

vision standard at 49 CFR 391.41(b)(10). Her optometrist examined her
in 2017 and certified that she does not have diabetic retinopathy. She
holds an operator's license from New Jersey.

Darby J. Russo

    Mr. Russo, 57, has had ITDM since 2010. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Russo understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Russo meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he does not
have diabetic retinopathy. He holds an operator's license from
Louisiana.

Gary S. Schreiner

    Mr. Schreiner, 63, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Schreiner understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Schreiner meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he does not
have diabetic retinopathy. He holds an operator's license from Florida.

Nicholas A. Scialanca

    Mr. Scialanca, 23, has had ITDM since 2010. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Scialanca understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Scialanca meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Pennsylvania.

Robert C. Scott

    Mr. Scott, 43, has had ITDM since 2015. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Scott understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Scott meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Wisconsin.

Thermond D. Smith

    Mr. Smith, 58, has had ITDM since 2016. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Smith understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Smith meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Illinois.

Edward D. Smith

    Mr. Smith, 52, has had ITDM since 2013. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Smith understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Smith meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Nebraska.

Jeffrey W. Stamper

    Mr. Stamper, 51, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Stamper understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Stamper meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2017 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Missouri.

Wayne R. Steffler

    Mr. Steffler, 60, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Steffler understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Steffler meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from New York.

Thomas J. Stylc

    Mr. Stylc, 59, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in

the last five years. His endocrinologist certifies that Mr. Stylc
understands diabetes management and monitoring, has stable control of
his diabetes using insulin, and is able to drive a CMV safely. Mr.
Stylc meets the requirements of the vision standard at 49 CFR
391.41(b)(10). His optometrist examined him in 2017 and certified that
he does not have diabetic retinopathy. He holds a Class A CDL from
Pennsylvania.

Todd A. Vanwinkle

    Mr. Vanwinkle, 53, has had ITDM since 2010. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Vanwinkle understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Vanwinkle meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Nebraska.

Jacob W. Williams

    Mr. Williams, 41, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Williams understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Williams meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Pennsylvania.

Kevin A. Wiswell

    Mr. Wiswell, 59, has had ITDM since 2017. His endocrinologist
examined him in 2017 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Wiswell understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Wiswell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2017 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Maine.

III. Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated in the dates
section of the notice.

IV. Submitting Comments

    You may submit your comments and material online or by fax, mail,
or hand delivery, but please use only one of these means. FMCSA
recommends that you include your name and a mailing address, an email
address, or a phone number in the body of your document so that FMCSA
can contact you if there are questions regarding your submission.
    To submit your comment online, go to http://www.regulations.gov and
in the search box insert the docket number FMCSA-2017-0286 and click
the search button. When the new screen appears, click on the blue
``Comment Now!'' button on the right hand side of the page. On the new
page, enter information required including the specific section of this
document to which each comment applies, and provide a reason for each
suggestion or recommendation. If you submit your comments by mail or
hand delivery, submit them in an unbound format, no larger than 8\1/2\
by 11 inches, suitable for copying and electronic filing. If you submit
comments by mail and would like to know that they reached the facility,
please enclose a stamped, self-addressed postcard or envelope.
    We will consider all comments and materials received during the
comment period. FMCSA may issue a final determination at any time after
the close of the comment period.

V. Viewing Comments and Documents

    To view comments, as well as any documents mentioned in this
preamble, go to http://www.regulations.gov and in the search box insert
the docket number FMCSA-2017-0286 and click ``Search.'' Next, click
``Open Docket Folder'' and you will find all documents and comments
related to this notice.

    Issued on: January 5, 2018.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2018-00561 Filed 1-12-18; 8:45 am]
 BILLING CODE 4910-EX-P


Tier 3 Phone & E-Mail Log

Includes substantive telephone conversations and e-mails between EPA
personnel and non-government stakeholders following signature of the
Tier 3 Notice of Proposed Rulemaking on March 30, 2013 (separate memos
on additional calls/emails have also been docketed individually).

Date	EPA Personnel	Stakeholder	Purpose of Call/E-mail and Topics(s)
Discussed

4/19/13	Paul Machiele	BP - Bob Leidich	Called to discuss response to
Senator Donnelly regarding the BP Whiting refinery

4/22/13	Paul Machiele	BP - Bob Leidich	Follow up on Friday’s
conversation regarding BP’s discussions with Senator Donnelly
regarding the BP Whiting refinery

4/23/2013	Jeff Herzog	American Fuel & Petrochemical Manufacturers (AFPM)
- Tim Hogan	Tim Hogan called to ask when EPA hoped to finalize in-use
fuel quality standards for higher level ethanol blends (i.e., E16-E50
and E51-83).  I related that depending on the comments we receive, EPA
could finalize such standards as part of the Tier 3 final rule or might
defer doing so until a later action.

4/24/2013	Jeff Herzog	Hart Energy – Paul Niznik	Paul Niznik called to
discuss the proposed sulfur requirements for gasoline additives.

4/24/13	Aron Butler	ICM – Steve Vander Griend	Phone call in response
to his email questions about EPAct/V2/E-89 and EPA Full-Useful-Life PM
studies

4/24/13	Aron Butler	ICM – Steve Vander Griend	Emailed him a copy of
Sobotowski docket memo on EPA Full-Useful-Life PM study

4/25/13	Alan Stout	Bob Maxwell	Early banking under §86.1811-17(b)(9).

4/29/13	Jeff Herzog	Weaver LLP – Vance Kopp, Ron Chapman, and Bill
Newman	Weaver LLP called to discuss the memo to the docket entitled
“Possible Approach to Fuel Quality Standards for Fuel Used in
Flexible-Fuel Automotive Spark-Ignition Vehicles (FFVs)”.

5/9/13	Aron Butler	ICM, Inc – Steve Vander Griend	Emailed him a copy
of EPA Full-Useful-Life PM study dataset (also placed into the docket)

5/9/13	Jeff Herzog	Innospec – Ian Macmillan	Ian Macmillan called to
discuss the proposed requirements for gasoline additives.

5/22/13	Jeff Herzog, Chris Brunner, Chris McKenna, and Tia Sutton	Weaver
LLP – Vance Kopp, Ron Chapman, Bill Newman, and Greg Stadi	Weaver LLP
called to discuss the following: Butane Blending, E51+ Fuels, RFG/CG
Compliance Pool Volumes, Average Annual Properties, Reporting
Requirements, Attest Report Date Change, Attest Requirements, and RCO
Signature for Sampling.

5/22/13	Jeff Herzog and Paul Machiele	Renewable Fuels Association-
Kristi Moore and Geoff Cooper	Phone discussion about the memo to the
docket entitled “Possible Approach to Fuel Quality Standards for Fuel
Used in Flexible-Fuel Automotive Spark-Ignition Vehicles (FFVs)”

5/22/13	Alan Stout	Bob Maxwell	PM standards for Interim Tier 3 diesel
vehicles

5/28	Aron Butler, Paul Machiele, Jim Warila, Rafal Sobotowski	ICM, Inc -
Steve Vander Griend and Greg Krissek	Conference call to discuss EPAct
fuel effects study design and results, focused primarily on the effects
of ethanol on fuel properties and emissions.

5/31/13	Jeff Herzog and Paul Machiele	National Environmental Strategies
– Richard Wilson.

Sunoco Logistics - Keith Buchanan and John Harkins	Phone discussion
about the downstream blending of pentane into gasoline.

6/6/13	Aron Butler	ICM, Inc – Steve Vander Griend	Email reply to
questions from Mr. Vander Griend.  Body of email discusses effects of
ethanol blending on fuel properties and the related emission impacts as
suggested by the EPAct fuel effects study.

6/14/13	Jeff Herzog	Flint Hills Resources - Rita Hardy and Philip
Guilemette	Phone discussion about the memo to the Tier 3 docket on
in-use fuel quality standards for E51-83.

6/18/13	Jeff Herzog	Marathon – Russ Lewis	Phone discussion about the
potential application of the RVP model referenced in the ASTM standard
for E51-83 to the blending of natural gasoline.

6/18/13	Jeff Herzog	Marathon – Mike Leister	Phone discussion about:
The refining industry’s position in EPA’s envisioned approach to
setting fuel quality standards for E51-83.   EPA’s legal ability to
finalize in-use standards based on comments solicited in the memo to the
docket entitled “Possible Approach to Fuel Quality Standards for Fuel
Used in Flexible-Fuel Automotive Spark-Ignition Vehicles (FFVs)”.

6/19/13	Jeff Herzog	Marathon – Mike Leister	Phone discussion about:
The refining industry’s position on EPA’s envisioned approach to
setting fuel quality standards for E51-83.   The validation of an
analytical RVP blending model to cover the use of natural gasoline and
butane as a blendstock in the manufacture of E51-83.  Setting
appropriate sulfur and benzene standards for the natural gasoline used
to manufacture E51-83.  EPA’s legal ability to finalize in-use
standards based on comments solicited in the memo to the docket entitled
“Possible Approach to Fuel Quality Standards for Fuel Used in
Flexible-Fuel Automotive Spark-Ignition Vehicles (FFVs)”.

6/19/13	Jeff Herzog	BP – Jim Simnick	Phone discussion about: The
refining industry’s position on EPA’s envisioned approach to setting
fuel quality standards for E51-83.   The validation of an analytical RVP
blending model to cover the use of natural gasoline and butane as a
blendstock in the manufacture of E51-83.  Setting appropriate sulfur and
benzene standards for the natural gasoline used to manufacture E51-83.

6/20/13	Don Kopinski, Tony Fernandez, Glenn Passavant, Alan Stout	EMA--
Bob Jorgensen, Lisa Stegink	EMA staff called to clarify points in the
NPRM regarding heavy-duty engine and vehicle certification, to assist
them in drafting EMA comments

6/21/13	Aron Butler	ICM, Inc – Steve Vander Griend	Email reply to
questions from Mr. Vander Griend.  Text of email discusses calculation
of fuel economy including the R-factor.  Attached a docket memo from
James Warila describing analysis of fuel effects on CO2 emissions based
on the EPAct study data.

6/21/13	Aron Butler	ICM, Inc – Steve Vander Griend	Email reply to
questions from Mr. Vander Griend.  Text of email discusses properties of
test fuels used in E15 full useful life PM study.  Attached are three
documents showing analysis of said test fuels (also placed into the
docket).

7/18/13	Jeff Herzog	Marathon—Jim Ellerbe	Phone discussion about the
qualification of natural gasoline used an E51-83 blending component as
substantially similar as discussed in the memo to the docket entitled
“Possible Approach to Fuel Quality Standards for Fuel Used in
Flexible-Fuel Automotive Spark-Ignition Vehicles (FFVs)”.

7/22/13	Aron Butler	ICM, Inc – Steve Vander Griend	Email reply to
questions from Mr. Vander Griend.  Attached is a distillation analysis
of a test fuel used in the E15 full useful life PM study (also placed
into the docket).  Text of email is not substantive.

7/28/13	Jeff Herzog	Chrysler – Jim Frusti	Phone discussion about
in-use quality standards for E51-83

7/28/13	Jeff Herzog	GM - Bill Studzinski	Phone discussion about in-use
quality standards for E51-83

7/28/13	Jeff Herzog	Ford – Dominic Dicicco	Phone discussion about
in-use quality standards for E51-83

7/28/13	Jeff Herzog	GM – Coleman Jones	Phone discussion about in-use
quality standards for E51-83

8/20/13	Jeff Herzog, Paul Machiele, Tia Sutton, Lester Wyborny
Environment Canada- Jody Barclay, David Burke, Lisa Ryan, Leif
Stephanson	Video conference discussing Canada’s work on a gasoline
program similar to Tier 3; also discussed (generally) EPA, California,
and Canada’s gasoline standards.  (Following the call EPA sent
Environment Canada information on accessing the public docket system to
access comments received on the Tier 3 proposed rule.)

9/12/13	Jeff Herzog, Paul Machiele	GM – Coleman Jones and Bill
Studzinski

Chrysler – Jim Frusti

Ford – Dominic Dicicco	Phone discussion about the potential in-use
quality standards for E51-83 and the requirements for flexible fuel
vehicle exhaust emissions certification test fuel.

9/12/13	Jeff Herzog	GM – Coleman Jones	Phone discussion about the use
of a model to demonstrate compliance with E51-83 maximum RVP
requirements

9/13/13	Jeff Herzog	Sunoco Logistics – Keith Buchanan

National Environmental Strategies – Richard Wilson 	Phone discussion
about the provisions for downstream pentane blending into gasoline, and
pentane producer batch testing practices.

9/17/13	Jeff Herzog	Mid-Continent Energy – Larry Mattingly	Larry
Mattingly called to discuss allowing for testing tolerance in the
determination of compliance with a 10ppm sulfur standard for butane.  We
also discussed the potential for allowing butane to meet a sulfur
average as well as a cap standard somewhat higher than 10ppm.

9/18/13	Jeff Herzog	Mid-Continent Energy – Larry Mattingly	Phone
discussion about the potential application of a testing tolerance
regarding determination of compliance with a 10ppm sulfur standard for
gasoline and gasoline blendstocks.

9/18/13	Jeff Herzog	Environmental Strategies – Richard Wilson	Phone
discussion about the potential application of a testing tolerance
regarding determination of compliance with a 10ppm sulfur standard for
gasoline and gasoline blendstocks.

10/24/13	Jeff Herzog	Sunoco Logistics - Keith Buchanan 	Phone discussion
about the provisions for downstream pentane blending into gasoline and
in-use quality standards for E51-83.

9/24/13	Aron Butler	Alliance of Automobile Manufacturers - Valerie
Ughetta;	Email transmitting publicly-available data from EPA Tier 2
ultra-low sulfur study to Ms. Ughetta.  Email text discusses statements
in API’s comments to the Tier 3 docket that relate to the data.

9/30/13	Aron Butler	Alliance of Automobile Manufacturers - Valerie
Ughetta; Amicus Policy Group – Ellen Shapiro	Conference call to
discuss results of EPA Tier 2 ultra-low sulfur study and how they relate
to API’s comments on the Tier 3 proposal.

10/17/13	Aron Butler	ICM, Inc – Steve Vander Griend	Email reply to
questions from Mr. Vander Griend.  Subjects covered include how fuel
properties may affect elastomeric parts in the fuel system, and possible
explanations for high benzene levels observed in the market under the
current regulatory arrangements.

10/23/13	Aron Butler	Alliance of Automobile Manufacturers - Valerie
Ughetta;	Email transmitting PowerPoint slides containing some
supplemental plots made from the EPA Tier 2 ultra-low sulfur study data,
related to comments and questions that arose during the conference call
on 9/30.  Email text briefly described how the plots were made and what
they show.

10/25/13	Aron Butler	Alliance of Automobile Manufacturers – Valerie
Ughetta; Amicus Policy Group – Ellen Shapiro; General Motors Corp –
Bill Studzinski	Conference call with additional discussion of results of
EPA Tier 2 ultra-low sulfur study and the supplemental plots transmitted
on 10/23.  Conversation also covered the proposed changes to
certification test gasoline properties and how they might be updated for
the final rule.

10/28/13	Aron Butler	Alliance of Automobile Manufacturers – Valerie
Ughetta; Amicus Policy Group – Ellen Shapiro	Email transmitting
updated PowerPoint slides containing minor revisions and clarifications
to the material transmitted on 10/23.  Email text was not substantive.

10/30/13	Jeff Herzog	Renewable Fuels Association – Kelly Davis	Phone
discussion about potential approaches re the demonstration of compliance
with sulfur requirements for denatured fuel ethanol.

11/06/13	Alan Stout	Steve Horetski, GM	Phone discussion about (1) A/C
settings during the running loss test, (2) maximum permissible FELs for
durability testing (line crossing), and (3) applicability of evaporative
emission standards and test methods for natural gas (and dual-fuel)
vehicles.

11/08/13	Jeff Herzog	Halterman Fuels- Tracey King	E-Mail exchange to the
effect that we have nothing further to relate that has not already been
covered in discussions with Halterman regarding the development of Tier
3 gasoline test fuel specifications.

11/14/13	Jeff Herzog	Sunoco Logistics – Keith Buchanan 	Phone
discussion about the compliance assurance requirements associated with
potential provisions to allow downstream blending of pentane into
gasoline.

11/15/13	Jeff Herzog	Magellan – Bruce Heine	Phone discussion regarding
potential amendments to the requirements for previously certified
gasoline.

11/19/13	Jeff Herzog	Sunoco Logistics – Keith Buchanan	Phone call to
discuss precision and accuracy criteria for fuel parameter test
procedures used to test pentane.

11/20/13	Jeff Herzog	Renewable Fuels Association – Kelly Davis	Phone
discussion regarding potential recordkeeping requirements for batches of
denatured fuel ethanol.

11/21/13	Jeff Herzog	Magellan – Bruce Heine	Phone discussion regarding
potential amendments to the requirements for previously certified
gasoline.

11/22/13	Jeff Herzog	Sunoco Logistics – Keith Buchanan	Phone
discussion regarding enforcement and compliance assurance issues
associated with the potential provisions for downstream blending of
pentane into gasoline.

11/26/13	Jeff Herzog, Chris Brunner	Magellan – Bruce Heine, Todd
Demuth, Nick Huff, James O’Neal, Rod Lawrence	Phone discussion
regarding Magellan’s comments on potential amendments to the
requirements for previously certified gasoline and potential provisions
to allow downstream blending of pentane into gasoline.

12/3/13	Aron Butler	Brightline Capital – Elson Huang	Email response to
general questions about availability of E15 fuel, interactions between
fuel and vehicle standards

12/05/13	Jeff Herzog	Sunoco Logistics – Keith Buchanan	Phone
discussion regarding enforcement and compliance assurance issues
associated with the potential provisions for downstream blending of
pentane into gasoline.

12/9/13	Christine Brunner, Aron Butler, Jeff Herzog, Paul Machiele, Tia
Sutton, Lester Wyborny	Environment Canada—Jody Barclay, Jeff Guthrie,
Lisa Ryan, Leif Stephanson	Conference call with Environment Canada (EC).
 EC updated us on their progress with their upcoming gasoline sulfur
rule.  We also discussed aspects of the Tier 2 and Tier 3 gasoline
sulfur programs, namely credit trading and deficit carryforward, and how
these will fit into Canada’s program.

12/17/13	Jeff Herzog	Sunoco Logistics – Keith Buchanan	Phone
discussion regarding enforcement and compliance assurance issues
associated with the potential provisions for downstream blending of
pentane into gasoline.

12/18/13	Aron Butler	ICM, Inc – Steve Vander Griend	Email reply to
questions from Mr. Vander Griend.  Subjects covered include design of
test fuel matrix and exhaust speciation schedule for EPAct/V2/E-89 test
program.

January through December 2013 	Lester Wyborny, Russ Smith and Paul
Machiele	Representatives of Albermarle, ART, Axens, CDTech, Exxon-Mobil,
Haldor Topsoe, Merichem, Sinopec and UOP	Discussions at the 2013 AFPM
Annual Meeting, phone calls and e-mails to obtain additional information
about the costs and other implications of FCC feed hydrotreating and
postreating.

1/14/14	Aron Butler	ICM, Inc – Steve Vander Griend	Email reply to
questions from Mr. Vander Griend.  Subjects covered include fuel
blending properties of ethanol and design of test fuel matrix for
EPAct/V2/E-89 test program.

1/15/14	Jeff Herzog	Sunoco Logistics – Keith Buchanan	Phone discussion
regarding the potential provisions for downstream blending of pentane
into gasoline.

1/16/14	Jeff Herzog	Sunoco Logistics – Keith Buchanan	Phone discussion
regarding the potential specifications for pentane blended into gasoline
downstream of the refinery.

1/16/14	Jeff Herzog	Andrea Grant – Independent Fuel Terminal Operators
Association	Potential amendments to the testing provisions for importers
of gasoline by tank truck.

1/17/14	Jeff Herzog	Kelly Davis – Renewable Fuels Association
Allowable denaturants for use in the manufacture of denatured fuel
ethanol.

1/21/14	Jeff Herzog	Kelly Davis – Renewable Fuels Association
Definition of gasoline blendstocks for use as an ethanol denaturant in
the ASTM standard for denatured fuel ethanol.

1/23/14	Jeff Herzog	Chuck Corr – ADM

Kelly Davis - RFA	Possibility that changes to the ASTM definition of the
gasoline blendstocks that can be used to denature fuel ethanol might
help address potential environmental concerns about the use of
blendstocks with high/benzene aromatics content or liquids that are not
true gasoline blendstocks.

1/30/14	Jeff Herzog	ASTM workgroup on the ASTM Standard for denatured
fuel ethanol: Joe Sopata – EPA, Chuck Corr – ADM, Kelly Davis –
RFA, Kristi Moore – RFA, Sonia Bain – Marathon, Robert Reynolds –
RFA, Andy Pickard – Nucleus, Alan Morrison – CDFA, Dale Weiss –
Colonial Pipeline, William Spitzley – State of Michigan, Chris Guske
– Tate and Lyle, Jim McGetric – BP, Helen Doherty - Sunoco	Potential
changes to the ASTM definition of the gasoline blendstocks that can be
used to denature fuel ethanol that might help address potential
environmental concerns about the use of blendstocks with high/benzene
aromatics content or liquids that are not true gasoline blendstocks.

1/30/14	Jeff Herzog	Sunoco Logistics – Keith Buchanan	Phone discussion
regarding the potential provisions for downstream blending of pentane
into gasoline.

2/7/2014	Aron Butler	Alliance of Automobile Manufacturers – Valerie
Ughetta	Phone call to answer questions about changes to emission test
gasoline.

2/10/14	Jeff Herzog	ASTM workgroup on development of an ASTM Standard
for natural gasoline used as a blend component of ethanol flex fuel:
Chuck Corr – ADM, Kelly Davis – RFA, Kristi Moore – RFA, Sonia
Bain – Marathon, Andy Pickard – Nucleus, Doug Rathbun – State of
Illinois, Chris Guske – Tate and Lyle, Jim McGetrick – BP, Marilyn
Herman – Herman & Associates, Lew Gibbs – Consulting Engineer, John
Hawkins – Sunoco Logistics, Coleman Jones – GM, Norman Bradshaw –
OneOk Inc., Steve Vandergrind – ICM Inc., Teresa Alleman – NREL,
Russ Lewis – Marathon, Ben Sweat – POET, Jeff Farenback-Brateman –
Exxon Mobil, Leo Bonaparte – Marathon, Rodney Sweeney – OneOk inc.
Development of an ASTM standard for natural gasoline used as a blend
component of ethanol flex fuel.

2/12/2014	Alan Stout	Steve Horetski, GM	Lead time for transitioning to
E10 test fuel for refueling and spitback tests.

2/14/2014	Alan Stout	Bob Maxwell	Regulatory provision allowing for
submission of evaporative test data using California’s test
procedures.

2/18/2014	Alan Stout	Steve Horetski, GM	Regulatory provision related to
worst-case test fuel for exhaust and refueling tests.

  PAGE   \* MERGEFORMAT  4